EVENTS

MIXiii 2025
Mar
4
to Mar 5

MIXiii 2025

Meet Scinai Immunotherapeutics Ltd.’s Expert Team at MIXiii Health-Tech.IL 2025!

We invite you to connect with us and explore:

👉 The latest advancements in our innovative sdAb pipeline for inflammatory & Immunotherapy diseases.

👉 Our unique CDMO Bioservices—helping Israeli biotech innovators advance their drug development from early stage to Phase 3.

👉 Expert insight from our distinguished hashtag#biopharma team, bringing decades of experience in biotech drug development and manufacturing:

Amir Reichman, CEO – A seasoned biotech entrepreneur & global pharma executive, driving biotech products from early stage to market.

Dalit Fischer, CTO – Microbiologist with vast expertise in biotechnology process innovation.

Elad Mark, COO, Head of CDMO BU – A global tech transfer expert ensuring seamless scalability.

Solomon Gahtan, Director of BD- CDMO Expert

📅 Schedule a personal consultation with our experts and elevate your biotech development to the next level: https://lnkd.in/dn2E_Rjx

View Event →
BIO-Europe
Nov
4
to Nov 6

BIO-Europe

Scinai Immunotherapeutics Ltd. team is excited to attend the BIOEurope congress in  Stockholm, Sweden, from November 4–6, 2024. We invite investors, partners, and biopharma innovators to meet us!

Stop by our booth #150 to:

⚛️ Hear more about our promising product pipeline, including an innovative Anti-IL-17A/F #sdAb , addressing the significant unmet need of mild to moderate plaque psoriasis patients.

📈 Discover how our end-to-end boutique CDMO BioServices can optimize your process development and manufacturing and streamline your project- from lab to vial.

🤝 Meet our distinguished Biopharma team including CEO, Amir Reichman; and CTO Dalit Fischer ready to answer all your questions.

We look forward to seeing you there. Reach out to us to schedule a meeting at bd@scinai.com

View Event →
Expert Panel : Plaque Psoriasis. The Unmet Need & Scinai's Innovative Solution
Sep
18

Expert Panel : Plaque Psoriasis. The Unmet Need & Scinai's Innovative Solution

Join us for an in-depth exploration of the complex landscape of plaque psoriasis and the innovative use of Anti-IL-17 sdAb for intralesional treatment. Our distinguished panel will discuss: - The significant unmet needs in plaque psoriasis treatment - Introduce our innovative approach with Anti-IL-17 NanoAbs: * Unique benefits of local administration * Key stages of drug development * Clinical implications for patients.

Register here.

View Event →
Investor Webinar
Aug
20

Investor Webinar

Join us for a special webinar with Scinai CEO - Amir Reichman.

- Scinai's Q2 financial results & business update

- Updates on our continued position within NASDAQ

- Research and development milestones

- CDMO division commercialization progress

- Q&A

View Event →